Leaflet: information for the patient
Ibudol roll-on 50 mg/g gel container with ball applicator
Ibuprofen
Read this leaflet carefully because it contains important information for you.
Follow exactly the administration instructions of the medicine contained in this leaflet or those indicated by your doctor, pharmacist or nurse.
1. What isIbudol roll-onand what it is used for
2. What you need to know before starting to useIbudol roll-on
3. How to useIbudolroll-on
4. Possible side effects
5. Storage ofIbudolroll-on
6. Contents of the container and additional information
The ibuprofen, active ingredient of this medication, acts as a local analgesic and anti-inflammatory.
This medication is indicated in adults and adolescents from 12 years of age for the relief of mild and occasional pain and inflammation caused by: small bruises, blows, muscle strains (muscle pulls), torticollis (neck pain and stiffness) or other contractures, lower back pain and mild sprains resulting from a twist.
Be especially careful with Ibudol roll-onroll-on
Skin Reactions
Be especially careful with Ibudol roll-on:
Severe skin reactions, such as exfoliative dermatitis, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, drug reaction with eosinophilia and systemic symptoms (DRESS syndrome), generalized acute pustular psoriasis (PEGA), have been reported in association with ibuprofen treatment. Discontinue treatment with Ibudol roll-on and seek medical attention immediately if you notice any of the symptoms related to these severe skin reactions described in section 4
Use of other medications
Inform your doctor or pharmacist if you are using or have recently used any other medication, especially analgesics, even those purchased without a prescription.
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to become pregnant, consult your doctor or pharmacist before taking this medication.
Do not use Ibudol roll-on if you are in the last 3 months of pregnancy. Do not use Ibudol roll-on during the first 6 months of pregnancy unless it is clearly necessary and your doctor advises you to do so. If you need treatment during this period, use the lowest dose for the shortest possible time.
Oral forms of Ibudol (e.g., tablets) may cause adverse reactions in the fetus. It is unknown whether the same risk applies to Ibudol roll-on when used on the skin.
Use in children
Do not use this medication in children under 12 years old, due to the scarcity of data in this population.
Driving and operating machinery
No effects on the ability to drive vehicles and use machinery have been described when using Ibudol roll-on externally on the skin.
Follow exactly the following administration instructions, unless your doctor has given you different ones. Consult your doctor or pharmacist if you have any doubts.
This medication is only for topical use (only to be applied on the skin).
The normal dose is:
Adults and children over 12 years: apply a thin layer of the gel to the painful area 3 to 4 times a day and perform a gentle massage with the applicator ball itself, to facilitate its penetration.
Wash your hands after each application. Do not use for more than 7 consecutive days.
If symptoms worsen or persist after 7 days of treatment, or if irritation or redness occurs, you must consult your doctor
If you use more Ibudol roll-on than you should:
Due to its topical use, cases of poisoning are unlikely. However, if you have used this medication more than you should, or in case of accidental ingestion, go immediately to a medical center or call the Toxicological Information Service (Tel: 915620420), indicating the medication and the amount ingested, as it may cause: nausea, vomiting, abdominal pain, drowsiness, dizziness, spasms (cramps) and a drop in blood pressure.
Like all medicines,Ibudol roll-onmay cause side effects, although not everyone will experience them.
Like all medicines,Ibudol roll-onmay cause side effects, although not everyone will experience them.
Stop using Ibudol roll-on and seek medical attention immediately if you notice any of the following symptoms:
You may experience the following side effects:
If you consider any of the side effects you experience to be severe, or if you notice any side effect not mentioned in this leaflet, inform your doctor or pharmacist.
Reporting side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect not listed in this leaflet. You can also report them directly to the Spanish System for Pharmacovigilance of Medicinal Products for Human Use:www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep out of reach and sight of children.
No special storage conditions are required.
Do not use this medicine after the expiration date shown on the packaging, after CAD:
The expiration date is the last day of the month indicated.
Medicines should not be disposed of through drains or in the trash. Ask your pharmacist how to dispose of the packaging and medicines you no longer need. This will help protect the environment.
the environment.
Composition ofIbudolroll-on
Each gram of gel contains 50 mg of ibuprofen as the active ingredient.
The other components (excipients) are: ethanol at 96 percent, isopropyl alcohol, hydroxyethylcellulose, diethylene glycol monoethyl ether, caproilocaproyl macrogolglycerides, glycerol (E-422), sodium hydroxide (E-524) (15% aqueous solution), levo menthol, reflex aroma (camphor, menthone-iso, menthone-L, borneol, methyl salicylate, B.H.T (E-321) and purified water.
Appearance of the product and contents of the packaging
This medication is a transparent and colorless gel with a reflex aroma.
It is presented in containers with a ball applicator that contain 30 or 60 grams of gel.
Only some sizes of containers may be commercially available.
Holder of the marketing authorization:
Kern Pharma, S.L.
Venus, 72 – Pol. Ind.Colón II
08228 Terrassa – Barcelona
Spain
Responsible for manufacturing:
Farmasierra Manufacturing, S.L.
Ctra. de Irún km 26,200
San Sebastián de los Reyes 28709 (Madrid)
Spain
This prospectus has been reviewed in January 2024
The detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS) http://www.aemps.gob.es/
Have questions about this medication or your symptoms? Connect with a licensed doctor for guidance and personalized care.